Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Cardiff Oncology churns C-suite—Chutes & Ladders
Cardiff churns C-suite to advance cancer candidate. Lexeo lands Big Pharma cardiologist. Janux goes with Gilead vet Go as CMO.
Darren Incorvaia
,
Zoey Becker
Jan 30, 2026 8:30am
Merck, Moderna sustain 49% melanoma risk reduction at 5 years
Jan 20, 2026 8:50am
Guardant Health pens Merck & Co. cancer collab
Jan 19, 2026 8:10am
Fierce Pharma
Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO
Jan 16, 2026 1:00pm
2 pharmas turn Scrooge, returning biotechs' unwanted gifts
Dec 19, 2025 10:44am
Daiichi-Merck ph. 3 ADC program on pause after patient deaths
Dec 18, 2025 11:22am
